this study evaluated the cost-effectiveness and clinical safety of utilizing hetastarch in pump prime solutions and for colloid replacement postoperatively in conjunction with the platelet inhibitors , aspirin and persantine ( dipyridamole ) .
C0700020
persantine
C0012582
dipyridamole